ongterm outcome of patients with COVID-19 associated akut respiratory distress syndrome (cARDS)

• Conditions: COVID-19 and Follow-upLongCOVID Disease; J80.0

• Registration Number: DRKS00027856
• Lead Sponsor: niversitätsklinikum Carl Gustav Carus

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-18
• Study Completion: 2022-09-30
• Results First Posted: 2022-11-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 184

Inclusion Criteria

Treatment for acute respiratory distress syndrome at university hospital Dresden secondary to COVID-19 at admission to intensive care unite.

Exclusion Criteria

None

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients discharged alive from hospital participating in this study will be interviewed after 6, 12 and 24. Primary outcome is survival after hospital discharge.

Secondary Outcome Measures

Name	Time	Method
Secound aim is to evaluate the quality of live after cARDS, analyzed with telefon interview using the EQ-5D-5L score.